(NASDAQ: WHWK) Whitehawk Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 26.43%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 40.98%.
Whitehawk Therapeutics's earnings in 2025 is $27,614,000.On average, 5 Wall Street analysts forecast WHWK's earnings for 2025 to be -$36,519,124, with the lowest WHWK earnings forecast at -$62,325,595, and the highest WHWK earnings forecast at -$8,409,009. On average, 5 Wall Street analysts forecast WHWK's earnings for 2026 to be -$75,280,650, with the lowest WHWK earnings forecast at -$117,726,123, and the highest WHWK earnings forecast at -$47,980,815.
In 2027, WHWK is forecast to generate -$90,817,295 in earnings, with the lowest earnings forecast at -$117,726,123 and the highest earnings forecast at -$60,841,652.